本文由定制化的企业情报智能服务平台——【情报强企】提供

标签：#dental

图片来源：©VideaHealth

牙科人工智能（AI）平台VideaHealth实现了一个突破性的里程碑，美国食品药品监督管理局（FDA）批准了其最新产品Videa Dental Assist的510（k）许可。根据VideaHealth的新闻稿，该许可包括30多种人工智能算法，将人工智能检测范围扩大到所有最常见的牙科疾病。

Dental artificial intelligence (AI) platform VideaHealth has achieved a groundbreaking milestone with the United States Food and Drug Administration (FDA) granting 510(k) clearance for their latest product, Videa Dental Assist. The clearance includes more than 30 AI algorithms, expanding AI detections to cover all of the most common dental diseases, according to a press release from VideaHealth.

VideaHealth首席执行官Florian Hillen在新闻稿中表达了美国食品药品监督管理局批准的重要性，“这是美国食品药品监督管理局在医疗保健史上最大、最具影响力的批准之一，将提升每年由VideaAI支持的数千万患者的患者护理水平。我们现在是第一家为牙科中几乎所有疾病状态提供见解并能诊断儿科疾病的牙科AI公司支持数千名牙科临床医生为数百万患者提供更好的护理。"

Florian Hillen, CEO of VideaHealth, expressed the significance of this FDA clearance, stating in the press release, "This is one of the largest, most impactful FDA clearances in the history of health care and will elevate the patient care for the tens of millions of patients who are supported per year by VideaAI. We are now the first dental AI company offering insights for virtually every disease state in dentistry as well as enabling diagnosis of pediatric conditions. It furthers VideaHealth’s mission to support thousands of dental clinicians to provide better care to millions of patients."

这些新的清除应用包括根尖周射线透射、结石、3岁及以上儿童龋齿检测，以及许多其他人工智能模型。据说，这些模型可以实现所有年龄段的检测，改善了牙科专业人员的工作流程并节省了时间。值得注意的是，其中一些检测标志着世界上任何地方的监管机构首次发布此类检测，包括首次在牙科领域获得儿科放射学人工智能许可。

These new clearance applications include periapical radiolucencies, calculus, pediatric caries detection for ages 3 years and older, among many other AI models. These models are said to allow for detections across all ages, improving workflow and time-savings for dental professionals. Notably, some of these detections mark the first of their kind to be issued by a regulatory agency anywhere in the world, including the first pediatric radiology AI clearance in dentistry.

Heartland Dental临床运营高级副总裁Tim Quirt博士对VideaHealth不断扩大的人工智能能力表示兴奋，他在新闻稿中表示，“令人兴奋的是，VideaHealth的人工智能能力和创新范围不断扩大。我们很自豪能在这个快速发展的领域与VideaHealth合作，因为他们的愿景、使命和对提供者的承诺是无与伦比的。这是人工智能在帮助受支持的医生及其团队照顾患者需求方面迈出的又一大步，我们很高兴很快能提供这些扩展了我们所支持的范围内的功能。"

Dr Tim Quirt, Senior Vice President of Clinical Operations at Heartland Dental, expressed excitement about VideaHealth's expanding scope of AI capabilities, saying in the press release, "It is exciting that VideaHealth’s scope of AI capabilities and innovations continue to expand. We are proud to partner with VideaHealth in this fast-moving field because their vision, mission, and commitment to providers are unparalleled. This is another big step forward for AI to assist supported doctors and their teams in caring for their patients’ needs, and we are excited to soon offer these expanded capabilities across our supported footprint."

据VideaHealth报道，VideaAI已经被数千名临床医生所接受，已成为许多人选择的牙科人工智能工具，每天用于为数百万患者提供尽可能好的护理。随着美国食品药品监督管理局最近的批准，VideaHealth旨在巩固其作为第一家为几乎所有疾病状态提供见解的牙科人工智能公司的地位。

Already embraced by thousands of clinicians, per VideaHealth, VideaAI has become the dental AI tool of choice for many, used daily to provide the best possible care for millions of patients. With this recent FDA clearance, VideaHealth aims to solidify its position as the first dental AI company to offer insights for virtually every disease state.

本文来源于网络资料，由【情报强企】整理